Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling

Show other versions (1)

Bibliographic Details
Main Authors:	Chaohao Li, Derek B. Allison, Daheng He, Fengyi Mao, Xinyi Wang, Piotr Rychahou, Ibrahim A. Imam, Yifan Kong, Qiongsi Zhang, Yanquan Zhang, Jinghui Liu, Ruixin Wang, Xiongjian Rao, Sai Wu, B. Mark Evers, Qing Shao, Chi Wang, Zhiguo Li, Xiaoqi Liu
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2023-11-01
Series:	PLoS Genetics
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662729/?tool=EBI

Similar Items

Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signaling.
by: Chaohao Li, et al.
Published: (2023-11-01)

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
by: Zhuangzhuang Zhang, et al.
Published: (2022-07-01)

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
by: Zhuangzhuang Zhang, et al.
Published: (2021-07-01)

PBK correlates with prognosis, immune escape and drug response in LUAD
by: Hongyu Ma, et al.
Published: (2023-11-01)

STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment
by: Yadong Li, et al.
Published: (2023-01-01)

Immune Subtypes in LUAD Identify Novel Tumor Microenvironment Profiles With Prognostic and Therapeutic Implications
by: Feng Wang, et al.
Published: (2022-06-01)

Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
by: Song Bing, et al.
Published: (2012-02-01)

Construction of a Prognostic and Early Diagnosis Model for LUAD Based on Necroptosis Gene Signature and Exploration of Immunotherapy Potential
by: Baizhuo Zhang, et al.
Published: (2022-10-01)

MDFI is a novel biomarker for poor prognosis in LUAD
by: Pengyu Chen, et al.
Published: (2022-10-01)

High BRCA1 expression is an independent prognostic biomarker in LUAD and correlates with immune infiltration
by: Fengzhu Guo, et al.
Published: (2023-04-01)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
by: Zhiqi Zhang, et al.
Published: (2023-11-01)

Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD
by: Wenjun Ren, et al.
Published: (2022-07-01)

The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD
by: Yinggang Che, et al.
Published: (2022-02-01)

Pan-cancer landscape of CENPO and its underlying mechanism in LUAD
by: Tongdong Shi, et al.
Published: (2023-04-01)

Genomic and immunogenomic analysis of three prognostic signature genes in LUAD
by: Hai-Ming Feng, et al.
Published: (2023-01-01)

PLK1, A Potential Target for Cancer Therapy
by: Zhixian Liu, et al.
Published: (2017-02-01)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
by: Yu Wang, et al.
Published: (2023-02-01)

Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
by: Weina Yu, et al.
Published: (2022-01-01)

The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
by: Linhai Fu, et al.
Published: (2020-01-01)

How the AHR Became Important in Cancer: The Role of Chronically Active AHR in Cancer Aggression
by: Zhongyan Wang, et al.
Published: (2020-12-01)

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
by: Zhenghai Shen, et al.
Published: (2022-09-01)

Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)
by: Fang Lv, et al.
Published: (2021-06-01)

Novel method to integrate MARG and an odometer into AHRS for moving vehicles
by: Chao Li, et al.
Published: (2017-09-01)

Prognostic gene HLA‐DMA associated with cell cycle and immune infiltrates in LUAD
by: Ya‐jie Huang, et al.
Published: (2023-12-01)

The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
by: Marco Gargaro, et al.
Published: (2021-01-01)

Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs)
by: Stephen Safe, et al.
Published: (2020-09-01)

Design and Implementation of an AHRS Based on MEMS Sensors and Complementary Filtering
by: Yangzhu Wang, et al.
Published: (2014-08-01)

A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs
by: Yang Liu, et al.
Published: (2022-09-01)

RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation
by: Lian Zhang, et al.
Published: (2023-02-01)

SLC2As as diagnostic markers and therapeutic targets in LUAD patients through bioinformatic analysis
by: Yanli Zhang, et al.
Published: (2022-11-01)

Inhibition of Fatty Acid Synthase Upregulates Expression of CD36 to Sustain Proliferation of Colorectal Cancer Cells
by: James Drury, et al.
Published: (2020-07-01)

Generation of dual-gRNA library for combinatorial CRISPR screening of synthetic lethal gene pairs
by: Shan Tang, et al.
Published: (2022-09-01)

Intratumor heterogeneity of driver mutations and TMB distribution in 30 early-stage LUAD patients with multiple lesions
by: Yuan Qiu, et al.
Published: (2022-08-01)

Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
by: Ingrid Hoffmann
Published: (2022-02-01)

Allele frequency deviation (AFD) as a new prognostic model to predict overall survival in lung adenocarcinoma (LUAD)
by: Aisha Al-Dherasi, et al.
Published: (2021-08-01)

AHR Roundtable You the People
by: Barreyre, N, et al.
Published: (2014)

Gut Microbiota Regulation of AHR Signaling in Liver Disease
by: Baohong Wang, et al.
Published: (2022-09-01)

When AHR signaling pathways meet viral infections
by: Jieke Hu, et al.
Published: (2023-02-01)

PLK UUM sumbang mesin basuh
by: Sinar, Harian
Published: (2012)

Revealing underlying regulatory mechanisms of LINC00313 in Osimertinib-resistant LUAD cells by ceRNA network analysis
by: Dandan Ding, et al.
Published: (2024-05-01)